Santen Pharmaceutical. (4536.TSE) Q1 2025 Earnings

6FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
17
20
23
27

Details

Expected EPS
25
Actual EPS
24
Surprise EPS
-1
Surprise Percent
+3%

Description

Santen Pharmaceutical. (4536.TSE) has reported earnings of 24 per share for Q1 2025.

0 Comments

Share your thoughts